Submitted by Anonymous (not verified) on 15 February 2024 - 15:34
Veterinary medicines European public assessment report (EPAR): Prolevare, oclacitinib maleate, Status: Authorised
Source:
Veterinary medicines European public assessment report (EPAR): Prolevare, oclacitinib maleate, Status: Authorised